L2L Group

You could argue, in many respects, that pharmaceutical and healthcare consulting firms form the position of a referee, or maybe even an arbitrator, challenging conventions and bringing a real world perspective to bear, both in the boardroom and in the training class. The pharmaceutical company has many, considerable challenges, not the least of which is the ability to generate the latest and most advantageous products for the end-user in a highly regulated and emotionally charged environment. We know that the pharmaceutical industry represents one of the most significant driving forces within any country's economy and as the stakes are so high, the levels of complexity encountered by pharmaceutical company management at every level are extraordinary. Pharmaceutical and healthcare consulting firms are able to take a somewhat independent role and may even be able to stand back and look at the challenges facing the client company, through experience, know-how and positioning, when the hurdles might seem too great.

With more and more niche products becoming available in the marketplace, an entire industry becoming more mature and a market that is far more educated and immediately aware than ever before, the road ahead is indeed challenging. This is where pharma training instructors will really come into their own and be available to suggest alternatives and options when needed. Established tactics may well need to be modified to take into account changes in the marketplace and this may often need to be achieved in short order and without the luxury of advance planning and preparation.

In many respects, certain clients may represent more of a partner, than simply a party within a strict seller-buyer relationship. These all-important accounts will require careful handling by those responsible and this goes far beyond the simple provision of products in return for financial remuneration. Key account management training will help key employees to service these top accounts correctly, whether this means the supply of critical and partial information from time to time, or the provisioning of other business intelligence.

They say that we are living in the age of communication and that we are all more powerful as a result of this. As education is so relatively easy to access and as end-users are likely to be much more aware of their options, the pharmaceutical sales force must be one step ahead of the game. Training must be sophisticated enough so that the sales force is able to anticipate a wide new range of potential questions and stumbling blocks, most especially when dealing with key account management training. Such accounts will likely take on even more importance going forward.

The market is now more sophisticated than ever before and is increasingly dynamic. Pharmaceutical company senior management cannot expect to be able to devote time and resources to their own raft of daily tasks while trying to keep on top of such a rapidly changing market environment. This is why pharmaceutical and healthcare consulting organisations should be engaged to bring their level of currency and ability to the table.